103 related articles for article (PubMed ID: 3257164)
1. Latent transformed growth-inhibiting factor in human malignant effusions.
Podolsky DK; Pleskow DK; Jafari H
Cancer Res; 1988 Jan; 48(2):418-24. PubMed ID: 3257164
[TBL] [Abstract][Full Text] [Related]
2. Multiplicity of transforming growth factors in human malignant effusions.
Seo MK; Lynch KE; Podolsky DK
Cancer Res; 1988 Apr; 48(7):1792-7. PubMed ID: 2894891
[TBL] [Abstract][Full Text] [Related]
3. Purification and characterization of a novel transforming growth factor.
Halper J; Moses HL
Cancer Res; 1987 Sep; 47(17):4552-9. PubMed ID: 2887280
[TBL] [Abstract][Full Text] [Related]
4. Purification and biological properties of type beta transforming growth factor from mouse transformed cells.
Fernandez-Pol JA; Klos DJ; Grant GA
Cancer Res; 1986 Oct; 46(10):5153-61. PubMed ID: 3489522
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factors in solid human malignant neoplasms.
Nickell KA; Halper J; Moses HL
Cancer Res; 1983 May; 43(5):1966-71. PubMed ID: 6299535
[TBL] [Abstract][Full Text] [Related]
6. Identification of a protein factor secreted by 3T3-L1 preadipocytes inhibitory for the human MCF-7 breast cancer cell line.
Johnston PG; Rondinone CM; Voeller D; Allegra CJ
Cancer Res; 1992 Dec; 52(24):6860-5. PubMed ID: 1458474
[TBL] [Abstract][Full Text] [Related]
7. Isolation of tumor cell growth-inhibiting factors from a human rhabdomyosarcoma cell line.
Iwata KK; Fryling CM; Knott WB; Todaro GJ
Cancer Res; 1985 Jun; 45(6):2689-94. PubMed ID: 3857121
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor production by chemically transformed cells.
Moses HL; Branum EL; Proper JA; Robinson RA
Cancer Res; 1981 Jul; 41(7):2842-8. PubMed ID: 6265069
[TBL] [Abstract][Full Text] [Related]
9. Epithelial tissue-derived growth factor-like polypeptides.
Halper J; Moses HL
Cancer Res; 1983 May; 43(5):1972-9. PubMed ID: 6572559
[TBL] [Abstract][Full Text] [Related]
10. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R
J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of anchorage-independent growth of human tumor cells by interleukin 1.
Hamburger AW; Lurie KA; Condon ME
Cancer Res; 1987 Nov; 47(21):5612-5. PubMed ID: 3499215
[TBL] [Abstract][Full Text] [Related]
12. Two distinct tumor cell growth-inhibiting factors from a human rhabdomyosarcoma cell line.
Fryling CM; Iwata KK; Johnson PA; Knott WB; Todaro GJ
Cancer Res; 1985 Jun; 45(6):2695-9. PubMed ID: 2580626
[TBL] [Abstract][Full Text] [Related]
13. Presence of transforming growth factors in human breast cancer cells.
Salomon DS; Zwiebel JA; Bano M; Losonczy I; Fehnel P; Kidwell WR
Cancer Res; 1984 Sep; 44(9):4069-77. PubMed ID: 6331663
[TBL] [Abstract][Full Text] [Related]
14. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene.
Liu J; Spence MJ; Wallace PM; Forcier K; Hellström I; Vestal RE
Cell Growth Differ; 1997 Jun; 8(6):667-76. PubMed ID: 9186000
[TBL] [Abstract][Full Text] [Related]
15. Identification of endogenous inhibitory growth factors from a human colon carcinoma cell line.
Levine AE; McRae LJ; Hamilton DA; Brattain DE; Yeoman LC; Brattain MG
Cancer Res; 1985 May; 45(5):2248-54. PubMed ID: 3857117
[TBL] [Abstract][Full Text] [Related]
16. Autocrine tumor cell growth-inhibiting activities from human malignant melanoma.
Bogdahn U; Apfel R; Hahn M; Gerlach M; Behl C; Hoppe J; Martin R
Cancer Res; 1989 Oct; 49(19):5358-63. PubMed ID: 2766302
[TBL] [Abstract][Full Text] [Related]
17. Alterations in both heparan sulfate proteoglycans and mitogenic activity of fibroblast growth factor-2 are triggered by inhibitors of proliferation in normal and breast cancer epithelial cells.
Lambrecht V; Le Bourhis X; Toillon RA; Boilly B; Hondermarck H
Exp Cell Res; 1998 Dec; 245(2):239-44. PubMed ID: 9851863
[TBL] [Abstract][Full Text] [Related]
18. High-molecular-weight transforming growth factor activity in the urine of patients with disseminated cancer.
Sherwin SA; Twardzik DR; Bohn WH; Cockley KD; Todaro GJ
Cancer Res; 1983 Jan; 43(1):403-7. PubMed ID: 6600160
[TBL] [Abstract][Full Text] [Related]
19. Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer.
Tong AW; Papayoti MH; Netto G; Armstrong DT; Ordonez G; Lawson JM; Stone MJ
Clin Cancer Res; 2001 Mar; 7(3):691-703. PubMed ID: 11297266
[TBL] [Abstract][Full Text] [Related]
20. Human brain tumor-associated urinary high molecular weight transforming growth factor: a high molecular weight form of epidermal growth factor.
Stromberg K; Hudgins WR; Dorman LS; Henderson LE; Sowder RC; Sherrell BJ; Mount CD; Orth DN
Cancer Res; 1987 Feb; 47(4):1190-6. PubMed ID: 3026622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
